DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer

BACKGROUND: Studies have shown that DAB2IP inhibits cancer progression, while HSP90AA1 promotes cancer progression. However, the specific regulatory mechanism of DAB2IP and HSP90AA1 in colorectal cancer (CRC) is not clear. Our aim is to investigate the role and mechanism of DAB2IP and HSP90AA1 in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mengna, Peng, Yanan, Yang, Zhenwei, Zhang, Hailin, Xu, Cong, Liu, Lan, Zhao, Qiu, Wu, Jixiong, Wang, Hongling, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118737/
https://www.ncbi.nlm.nih.gov/pubmed/35590292
http://dx.doi.org/10.1186/s12885-022-09596-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118737/
https://www.ncbi.nlm.nih.gov/pubmed/35590292
http://dx.doi.org/10.1186/s12885-022-09596-z

Ejemplares similares